Literature DB >> 2228317

Tumor necrosis factor-alpha and interleukin-1 alpha production in cachectic, tumor-bearing mice.

C Lönnroth1, L L Moldawer, J Gelin, L Kindblom, B Sherry, K Lundholm.   

Abstract

Weight-stable mice bearing a syngeneic, methylcholanthrene-induced, rapidly growing tumor lost approximately 22% of their lean tissue, became significantly hypoalbuminemic and had a marked increase in serum amyloid P concentrations during progressive tumor growth. Tumors from cachectic mice were producing both TNF-alpha and IL-1 alpha in vivo as documented by the presence of TNF-alpha and IL-1 alpha mRNA and immune-reactive protein for IL-1 alpha. Only spleens from tumor-bearing mice had statistically significantly elevated quantities of IL-1 mRNA. In general, alterations in tissue concentrations of IL-1 mRNA in tumor-bearing animals agreed qualitatively with those found in endotoxin-stimulated, non-tumor-bearing control mice. However, endotoxin-stimulated mice had significantly elevated tissue concentrations of TNF mRNA in spleen and livers, while TNF mRNA levels were not significantly increased in any host tissues. Cytokine mRNA levels in tumor tissue were not higher than those found constitutively in various tissues from non-tumor-bearing control animals. Plasma from tumor-bearing mice and endotoxin-stimulated controls contained high levels of IL-6 but low (endotoxin-stim.) or no measurable levels (tumor-bearing) of either IL-1 or TNF. When tumor cells from cachectic mice were placed into long-term cell culture, immune reactive TNF-alpha and IL-1 alpha were produced, but IL-6 bioactivity ws not produced in measurable amounts.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2228317     DOI: 10.1002/ijc.2910460523

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  10 in total

1.  Protein turnover, synthesis and secretion of albumin in hepatocytes isolated from rats bearing Walker 256 carcinoma.

Authors:  P Villa; P Arioli; A Guaitani
Journal:  In Vitro Cell Dev Biol       Date:  1992-03

2.  Improvement by eicosanoids in cancer cachexia induced by LLC-IL6 transplantation.

Authors:  T Ohira; K Nishio; Y Ohe; H Arioka; M Nishio; Y Funayama; H Ogasawara; M Fukuda; K Yazawa; H Kato; N Saijo
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

Review 3.  Are cytokines possible mediators of cancer cachexia?

Authors:  Y Noguchi; T Yoshikawa; A Matsumoto; G Svaninger; J Gelin
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

4.  Interleukin-1 stimulates catabolism in C2C12 myotubes.

Authors:  Wei Li; Jennifer S Moylan; Melissa A Chambers; Jeffrey Smith; Michael B Reid
Journal:  Am J Physiol Cell Physiol       Date:  2009-07-22       Impact factor: 4.249

Review 5.  Myeloid-derived suppressor cells in cancer cachexia syndrome: a new explanation for an old problem.

Authors:  Robert D Winfield; Matthew J Delano; Kalyan Pande; Philip O Scumpia; Drake Laface; Lyle L Moldawer
Journal:  JPEN J Parenter Enteral Nutr       Date:  2008 Nov-Dec       Impact factor: 4.016

6.  Interleukin-6 cDNA transfected Lewis lung carcinoma cells show unaltered net tumour growth rate but cause weight loss and shortened survival in syngeneic mice.

Authors:  Y Ohe; E R Podack; K J Olsen; Y Miyahara; K Miura; H Saito; Y Koishihara; Y Ohsugi; T Ohira; K Nishio
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640

7.  Interactions between rnacrophage cytokines and eicosanoids in expression of antitumour activity.

Authors:  S Ben-Efraim
Journal:  Mediators Inflamm       Date:  1992       Impact factor: 4.711

8.  Cancer immunotherapy: potential involvement of mediators.

Authors:  S Ben-Efraim
Journal:  Mediators Inflamm       Date:  1997       Impact factor: 4.711

9.  The rationale for preventing cancer cachexia: targeting excessive fatty acid oxidation.

Authors:  Chao-Nan Qian
Journal:  Chin J Cancer       Date:  2016-07-21

10.  Increased proliferation of myoblasts after cyclic plasma perfusion of tumor-bearing rabbits.

Authors:  S Nakata; O Ishiko; K Honda; K Hirai; M Deguchi; S Ogita
Journal:  Jpn J Cancer Res       Date:  1998-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.